Cargando…
Evaluation of carboplatin sustained‐release delivery system in dogs with cancer
The objective of the study was to assess the carboplatin sustained‐release (CSR) as an injectable, biodegradable polymer system designed to uniformly release carboplatin over 30 days at a dose of 350 mg m(−2). The study involved seven client‐owned dogs with histologically or cytologically confirmed...
Autores principales: | Tansey Baldwin, Colleen, Zwahlen, Courtney H., Kirschner, Steven, Nakamura, Reid K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5645872/ https://www.ncbi.nlm.nih.gov/pubmed/29067189 http://dx.doi.org/10.1002/vms3.26 |
Ejemplares similares
-
Double-Emulsion Copolyester Microcapsules for Sustained Intraperitoneal Release of Carboplatin
por: Cymbaluk-Płoska, Aneta, et al.
Publicado: (2019) -
A prospective evaluation of rivaroxaban on haemostatic parameters in apparently healthy dogs
por: Evans, Liam A., et al.
Publicado: (2019) -
Evaluation of Weight Change During Carboplatin Therapy in Dogs With Appendicular Osteosarcoma
por: Story, A.L., et al.
Publicado: (2017) -
Gas-blasting nanocapsules to accelerate carboplatin lysosome release and nucleus delivery for prostate cancer treatment
por: Fu, Shunli, et al.
Publicado: (2021) -
Evaluation of bioabsorbable calcium sulfate hemihydrate beads for local delivery of carboplatin
por: Traverson, Marine, et al.
Publicado: (2020)